anti-CD49b antibody product blogThe CD49b cd49b (Catalog #MBS532027) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The CD49b antibody reacts with Murine CD49b and may cross-react with other species as described in the data sheet. MyBioSource\'s CD49b can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS). Researchers should empirically determine the suitability of the CD49b cd49b for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The CD49b cd49b product has the following accession number(s) (GI #303387045) (NCBI Accession #ADM15550.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Rat monoclonal CD49b antibody.
Biological Significance: CD49b (cluster of differentiation 49b) is a protein which in humans is encoded by the CD49b gene. The CD49b protein is an integrin alpha subunit. It makes up half of the alpha2Beta1 integrin duplex. Integrins are heterodimeric integral membrane glycoproteins composed of a distinct alpha chain and a common beta chain. Immunogen: CD49b antibody was raised in rat using RIL-2-propagated NK1.1 cells from C57BL/6 mice as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD49b are readily searchable from our website. Different antibodies against the same target such as CD49b may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.